Company News, Marketing News

Debut Raises $34 Million in Series B Funding Led by L’Oréal To Create Next Generation of Active Ingredients

Will develop a wide variety of components for beauty and personal care products using its proprietary biotechnology model.

Author Image

By: Lianna Albrizio

Associate Editor

Debut, a vertically-integrated synthetic biology company that is spearheading the creation of innovative and novel high-performing active ingredients in beauty, has raised $34 million Series B in a funding round led by Bold, the venture capital fund of L'Oréal.   Additional participating investors include Fine Structure Ventures, Material Impact, GS Futures, Cavallo Ventures, Cultivian Sandbox Ventures, ACVC Partners, and others.    As part of the strategic partnership with ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters